- Home
- DOMH vs PRPO Comparison
DOMH vs PRPO Comparison
Compare DOMH & PRPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DOMH | PRPO |
|---|---|---|
| Founded | 1967 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Laboratory Analytical Instruments |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 73.3M | 42.0M |
| IPO Year | 2010 | 2000 |
Fundamental Metrics
Financial Performance| Metric | DOMH | PRPO |
|---|---|---|
| Price | $2.60 | $29.70 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 179.8K | 104.8K |
| Earning Date | 05-12-2026 | 05-12-2026 |
| Dividend Yield | ★ 23.45% | N/A |
| EPS Growth | 34.03 | ★ 92.15 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $123,104,000.00 | $24,049,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 578.41 | 29.77 |
| 52 Week Low | $2.19 | $14.04 |
| 52 Week High | $8.40 | $33.63 |
Technical Indicators
Market Signals| Indicator | DOMH | PRPO |
|---|---|---|
| Relative Strength Index (RSI) | 46.57 | 75.23 |
| Support Level | $2.29 | $22.25 |
| Resistance Level | $3.42 | $33.63 |
| Average True Range (ATR) | 0.21 | 1.92 |
| MACD | 0.01 | 0.82 |
| Stochastic Oscillator | 23.68 | 100.00 |
Price Performance
Historical ComparisonAbout DOMH Dominari Holdings Inc.
Dominari Holdings Inc is a holding company that, through its various subsidiaries, is engaged in wealth management, investment banking, sales and trading, asset management, and insurance. In addition to capital investment, Dominari provides management support to the executive teams of its subsidiaries, helping them to operate efficiently and reduce costs under a streamlined infrastructure. The Company operates in two reportable business segments: Dominari Financial and Legacy AIkido, with the majority of revenue from Dominari Financial.
About PRPO Precipio Inc.
Precipio Inc is a healthcare biotechnology company focused on cancer diagnostics. Its objective is to enhance diagnostic accuracy & accessibility while building a sustainable business model that supports ongoing innovation. The company operates Clinical Laboratory Improvement Amendments laboratories in both New Haven, Connecticut, & Omaha, Nebraska, providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. The company operates in a single segment, which includes two divisions: the Pathology Services Division & the Products Division. The Pathology Services provides specialized cancer diagnostic testing services. The pathology services division specializes in diagnostic testing focused mainly on hematologic cancers.